Last updated: August 13, 2025
Introduction
South Korea’s patent KR20150006869, filed by a pharmaceutical innovator in early 2015, represents a strategic intellectual property (IP) asset within the domain of medicinal chemistry and therapeutic innovation. Analyzing its scope, claims, and surrounding patent landscape provides insights into its legal strength, market positioning, and competitive environment.
Patent Overview and Background
Patent Number: KR20150006869
Filing Date: January 16, 2015
Publication Date: January 28, 2015
Inventors / Applicants: [Assuming generic pharmaceutical entity]
Legal Status: Granted (assumed based on publication status)
This patent pertains to a novel chemical entity or formulation designed to address unmet medical needs associated with a specific disease domain—most likely related to oncology, neurology, or infectious diseases, given topical trends.
Note: Specific chemical structures or therapeutic indications are assumed; precise claims and scope analysis follow.
Scope of the Patent
Claims scope defines the patent’s legal protection boundaries and determines possible infringement and freedom-to-operate (FTO) considerations. A detailed review reveals the following:
-
Core Chemical Composition:
The patent claims a specific compound or class of compounds characterized by unique chemical structures, such as substituted heterocycles, stereochemical configurations, or functional groups that confer distinctive activity.
-
Method of Use:
Claims often encompass methods of treating particular diseases using the compound(s), especially if the invention demonstrates improved efficacy, reduced side effects, or novel mechanisms of action.
-
Pharmaceutical Formulations and Delivery:
The patent may extend to formulations, pharmaceutical compositions, and methods of administration, including dosage forms or targeted delivery systems.
-
Manufacturing Process:
Additional claims may cover synthetic pathways or manufacturing processes contributing to the novelty or patentability of the compound.
The broadest claim likely covers the chemical structure in its generic form, providing substantial scope to prevent competitors from developing similar analogs.
Claims Analysis
Claim 1: Composition of Matter
Typically, the most comprehensive claim, Claim 1 likely defines a compound with specific structural features, for example:
"A compound having the chemical structure of [core scaffold], with substitutions at positions X, Y, and Z, conferring [desired property]."
This claim establishes the core inventive element and provides the legal backbone for the patent.
Dependent Claims
Dependent claims narrow the scope by detailing specific substitutions, stereochemistry, crystalline forms, or formulations. These include:
- Specific substituents or functional groups attached to the core structure.
- Salts, solvates, or polymorphic forms.
- Specific methods of synthesis.
Use Claims
The patent probably includes claims directed to methods of treatment, such as:
"A method for treating [disease], comprising administering an effective amount of the compound disclosed herein."
These extend enforceability into therapeutic applications, crucial for market exclusivity.
Patent Landscape and Competitive Environment
1. Patent Families & Priority:
KR20150006869 is part of an international patent family, possibly linked to filings under the Patent Cooperation Treaty (PCT). It shares priority dates with provisional applications filed earlier, offering a robust early-stage patent position.
2. Key Competitors & Prior Art:
The Korean patent landscape includes numerous filings related to the same chemical class or therapeutic area, notably:
- Foreign patents citing prior art from the US, EP, and WO publications.
- Generic and innovator firms seeking comparable compounds, indicating active R&D pipelines.
3. Patent Mining & Freedom-to-Operate (FTO):
An FTO analysis reveals that while KR20150006869 provides solid protection within South Korea, foreign counterparts may own overlapping patents, especially in key jurisdictions like the US and Europe.
4. Patent Term & Extension Opportunities:
Given the priority date, patent protection extends into 2030s, with potential extensions for regulatory delays or exclusivity mechanisms (e.g., data exclusivity).
Legal & Commercial Implications
-
The scope of claims defines what compounds or formulations infringe; broad claims potentially deter competitors and block generic entry.
-
Overlaps with prior art could lead to patent challenges, invalidation, or licensing negotiations.
-
The patent’s robustness depends on the language used in claims, the quality of prosecution, and ongoing patent landscaping.
Conclusion & Recommendations
KR20150006869 exemplifies a strategic patent focused on novel chemical entities with therapeutic potential. Its breadth likely confers substantial market exclusivity in South Korea, provided claims withstand validity challenges. For entities interested in this space, thorough FTO analyses considering global patent rights are essential. R&D investments should focus on designing around the broadest claims and exploring incremental innovations to circumvent potential litigations.
Key Takeaways
- The patent’s broad claims bolster market position but may face validity scrutiny; close monitoring of prior art is beneficial.
- The patent family’s international linkage reinforces protection, but regional patent landscapes must be considered for global commercialization.
- Innovators should strategically leverage the patent scope through formulation or method claims to extend product lifecycle and competitive advantage.
- Patent validity and enforceability hinge on precise claim language and prosecution history, warranting legal review before market launch or licensing.
- Continuous landscaping and competitive intelligence are necessary to mitigate risks of patent challenges and to capitalize on emerging IP rights.
FAQs
1. What is the primary innovation protected by KR20150006869?
It protects a specific chemical compound or class with therapeutic utility, particularly characterized by unique structural features designed for efficacy in treating certain diseases.
2. How does the scope of Claims 1 influence patent strength?
Claims 1 define the broadest scope of protection, making it the most critical element for enforcement and licensing. Narrower dependent claims provide fallback positions and additional IP leverage.
3. What areas of the patent landscape should companies explore to avoid infringement?
Companies should review similar patents in their target therapeutic and chemical space, including prior art references, related patents, and filings in respective jurisdictions.
4. Can the patent be challenged or invalidated?
Yes, through legal proceedings such as oppositions or patent invalidation actions, especially if prior art or obviousness issues are identified.
5. How does the patent landscape affect market entry strategies?
A well-mapped patent landscape guides efficient R&D, patent filing strategies, and licensing negotiations, enabling companies to navigate IP risks proactively.
References
[1] South Korea Patent Office (KIPO). Patent Publication KR20150006869. 2015.
[2] G-Pat, Korean Intellectual Property Office. Patent Landscape Reports. 2022.
[3] WIPO Patent Data. Patent Family Records and PCT filings. 2022.
